Trypsin stimulates production of cytokines from peritoneal macrophages in vitro and in vivo

Pancreas

Volumn 21, Issue 1, 2000, Pages 41-51

  Lundberg, Andrew H ^a   Eubanks III, James W ^a   Henry, James ^a   Sabek, Omaima ^a   Kotb, Malak ^a   Gaber, Lillian ^a   Norby Teglund, Anna ^a   Gaber, A Osama ^a,b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cytokine; Pancreatitis; TNF ; Trypsin

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; PROTEINASE; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME RELEASE; MALE; NONHUMAN; PERITONEAL FLUID; PERITONEUM MACROPHAGE; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CYTOKINES; EDEMA; GENE EXPRESSION REGULATION; INTERLEUKIN-1; KINETICS; LUNG; MACROPHAGES, PERITONEAL; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRYPSIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033918530     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200007000-00050     Document Type: Article

References (47)

1. Grewal HP, Kotb M, el Din AM, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994;115:213-21.
2. Norman JG, Franz MG, Fink GS, et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995;221:625-31; discussion 631-4.
3. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor alpha. Cytokine 1991;3: 12-6.
4. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.
5. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis [see comments]. Gut 1993;34:41-5.
6. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101: 782-5.
7. Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22: 200-3.
8. Hughes CB, Henry J, Kotb M, Lobaschevsky A, Sabek O, Gaber AO. Up-regulation of TNF alpha mRNA in the rat spleen following induction of acute pancreatitis. J Surg Res 1995;59:687-93.
9. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83:919-23.
10. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-53.
11. Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 1994;167:214-8; discussion 218-9.
12. Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996;120:515-21.
13. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-55.
14. Norman JG, Fink G, Franz M, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 1996;223:163-9.
15. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-7.
16. Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice [see comments]. Surgery 1996;120:284-8; discussion 289.
17. Tracey KJ, Lowry SF. The role of cytokine mediators in septic shock. Adv Surg 1990;23:21-56.
18. Foitzik T, Fernandez-del Castillo C, Ferraro MJ, Mithofer K, Rattner DW, Warshaw AL. Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg 1995;222:179-85.
19. Renner IG, Savage WTd, Pantoja JL, Renner VJ. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985;30:1005-18.
20. Eubanks JW 3rd, Sabek O, Kotb M, et al. Acute pancreatitis induces cytokine production in endotoxin-resistant mice. Ann Surg 1998;227:904-11.
21. Hughes CB, Gaber LW, Kotb M, Mohey el-Din AB, Pabst M, Gaber AO. Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery 1995;117:201-5.
22. Scheele G, Adler G, Kern H. Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretagogue stimulation. Gastroenterology 1987;92:345-53.
23. Fernandez-del Castillo C, Schmidt J, Rattner DW, et al. Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat. Pancreas 1992;7:263-70.
24. Wedgwood KR, Adler G, Kern H, Reber HA. Effects of oral agents on pancreatic duct permeability: a model of acute alcoholic pancreatitis. Dig Dis Sci 1986;31:1081-8.
25. Harvey MH, Wedgwood KR, Austin JA, Reber HA. Pancreatic duct pressure, duct permeability and acute pancreatitis. Br J Surg 1989;76:859-62.
26. Foitzik T, Lewandrowski KB, Fernandez-del Castillo C, Rattner DW, Warshaw AL. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis. Surgery 1994; 115:698-702.
27. Heath DI, Wilson C, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994;35:1311-5.
28. Tracey KJ, Cerami A. Tumor necrosis factor: an updated review of its biology. Crit Care Med 1993;21(suppl 10):S415-22.
29. Sameshima H, Ikei S, Mori K, et al. The role of tumor necrosis factor-alpha in the aggravation of cerulein-induced pancreatitis in rats. Int J Pancreatol 1993;14:107-15.
30. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 1991;119:65-93.
31. Buggy JJ. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/ STAT pathway. Biochem J 1998;331:211-6.
32. Hughes CB, Gaber LW, Mohey el-Din AB, et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Snrg 1996;62:8-13.
33. Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/ tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989;170:1627-33.
34. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997;40:1-4.
35. Mannel DN. Biological aspects of tumor necrosis factor. Immunobiology 1986;172:283-90.
36. Lankisch PG, Ihse I. Bile-induced acute experimental pancreatitis. Scand J Gastroenterol 1987;22:257-60.
37. Geokas MC, Baltaxe HA, Banks PA, Silva J Jr, Frey CF. Acute pancreatitis. Ann Intern Med 1985;103:86-100.
38. Mithofer K, Fernandez-del Castillo C, Ferraro MJ, et al. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology 1996;110:232-10.
39. Foitzik T, Fernandez-del Castillo C, Lewandrowski KB, Rattner DW, Herfarth C, Warshaw AL. [Trypsinogen activation peptides in acute pancreatitis: experimental data and clinical implications]. Chirurgie 1994;65:186-9.
40. Okumura Y, Inoue H, Fujiyama Y, Bamba T. Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats. J Gastroenterol 1995;30:379-86.
41. Borgstrom A, Ohlsson K. Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe Sevlers Z Physiol Chem 1978;359:677-81.
42. Ohlsson K, Tegner H. Experimental pancreatitis in the dog: demonstration of trypsin in ascitic fluid, lymph and plasma. Scand J Gastroenterol 1973;8:129-33.
43. Chen HM, Shyr MH, Chen MF. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis. J Formos Med Assoc 1997;96:704-9.
44. Schmid S, UhI W, Buchler MW. Protease-antiprotease interactions and the rationale for therapeutic protease inhibitors. Scand J Gastroenterol Suppl 1996;219:47-50.
45. Speer CP, Pabst MJ, Hedegaard HB, Rest RF, Johnston RB Jr. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G. J Immunol 1984;133:2151-6.
46. Kim KU, Kwon OJ, Jue DM. Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate. Immunology 1993; 80:134-9.
47. Tahamont MV, Barie PS, Blumenstock FA, Hussain MH, Malik AB. Increased lung vascular permeability after pancreatitis and trypsin infusion. Am J Pathol 1982;109:15-26.